IRVINE, Calif.--(BUSINESS WIRE)--Diality Inc., a medical device company developing the Moda-flxTM Hemodialysis System, today announced that Ravi Parthasarathy has joined the company as Chief Technology Officer.
Parthasarathy comes to Diality with decades of product development team leadership experience, most recently with ICU Medical, where he served as Vice President, Device Engineering. Prior to ICU Medical, he served in leadership and product development roles for Baxter Healthcare, Motorola, Siemens Medical Systems, and General Motors.
“We are delighted to welcome someone of Ravi’s expertise and passion to Diality,” said Osman Khawar, M.D., CEO of Diality. “Ravi’s wealth of experience leading development of innovative products and his alignment with Diality’s mission, vision, and values make him a perfect fit for Diality and our current and future product portfolios.” As Diality continues to evolve, Clayton Poppe will also assume the role of Chief Scientific Officer (CSO) where he will lead the company’s research, quality, and regulatory functions.
The Moda-flxTM Hemodialysis System is a patient-inspired hemodialysis system designed to empower healthcare professionals to choose what is best for patients, as well as their clinical practice.
“Diality’s mission of improving lives impacted by kidney disease resonates very strongly with me and is one of the many reasons I am excited to help develop the Moda-flxTM Hemodialysis System," said Mr. Parthasarathy. “Dialysis patients deserve more innovation to improve their quality of life and the quality of their care.”
About Diality
Headquartered in Irvine, Calif., Diality is a medical device company developing the Moda-flxTM Hemodialysis System. Diality’s hemodialysis system is currently not approved for sale in any region. To learn more, please visit www.diality.com, and find us on LinkedIn.
